ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance

Hundley, W. Gregory; Bluemke, David A.; Finn, J. Paul; Flamm, Scott D.; Fogel, Mark A.; Friedrich, Matthias G.; Ho, Vincent B.; Jerosch‐Herold, Michael; Kramer, Christopher M.; Manning, Warren J.; Patel, Manesh R.; Pohost, Gerald M.; Stillman, Arthur E.; White, Richard D.; Woodard, Pamela K.

doi:10.1161/cir.0b013e3181d44a8f

Cited by 493 publications

(132 citation statements)

References 439 publications

(208 reference statements)

Supporting

Mentioning

121

Contrasting

Unclassified

Order By: Relevance

“…[40][41][42] This may be helpful as surrogate endpoints for intervention studies, as well as potentially add to global CVD risk assessment and guide treatment decisions. [43][44][45][46][47] Subclinical atherosclerosis is commonly assessed by carotid intima-media thickness (cIMT), coronary artery calcium score (CACS), coronary computed tomography angiography (CCTA) and cardiac magnetic resonance imaging (CMR). [5,[46][47][48][49][50][51][52][53][54][55][56][57][58] In recent years, some groups have started to evaluate these imaging techniques in former preeclampsia patients, as discussed below.…”

Section: Cardiovascular Imagingmentioning

confidence: 99%

“…[15] 2.4.3 Cardiac magnetic resonance imaging Cardiac magnetic resonance (CMR) is a non-invasive imaging technique that enables detailed soft tissue characterization and can assess different parameters of cardiovascular function, as well as macrovascular and microvascular features of CVD without using ionizing radiation. [45,81] In addition, enhancement of CMR with adenosine perfusion MRI (also called 'adenosine stress MRI') can be used to identify both ischemic coronary artery disease as well as non-obstructive coronary disease in symptomatic women without major plaques. [82] It is unclear whether or not there is a role for adenosine stress MRI in the detection of cardiac dysfunction in asymptomatic women.…”

Section: Coronary Artery Calcium Scorementioning

confidence: 99%

“…[85,86] Although sensitivity of CMR is high, the specificity is moderate for detecting major coronary artery lesions, and the availability and costs of CMR equipment currently limit large-scale use. [45] Another problem is the uncertainty of translating abnormal CMR findings observed at a young age to actual later-life CVD event risks, as longitudinal studies with sufficient follow-up time are not available. The use of CMR for screening purposes in asymptomatic, high-risk populations, such as women with a history of preeclampsia, needs to be further explored to establish a more conclusive role for CMR in the screening of CVD risk after preeclampsia.…”

Section: Coronary Artery Calcium Scorementioning

confidence: 99%

See 2 more Smart Citations

Determinants of future cardiovascular health in women with a history of preeclampsia

et al. 2015

View full text Add to dashboard Cite

Please cite this article as: Zoet Gerbrand A, Koster Maria PH, Velthuis Birgitta K, de Groot Christianne JM, Maas Angela HEM, Fauser Bart CJM, Franx Arie, Rijn Bas B.van.Determinants of future cardiovascular health in women with a history of preeclampsia.Maturitas http://dx.doi.org/10.1016/j.maturitas. 2015.07.004 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Keywords:Preeclampsia, cardiovascular disease, risk assessment, screening, prevention Highlights  Female-specific risk factors, among which preeclampsia, may have additional value in cardiovascular screening.  Non-invasive imaging techniques can be helpful to detect early-stage cardiovascular lesions as a sign of subclinical atherosclerotic disease.  Preliminary studies show positive effects of short-term lifestyle interventions following preeclampsia.  There is a need for clinical practice guidelines that provide long-term strategies in women after preeclampsia in pregnancy to improve cardiovascular health. AbstractWomen who develop preeclampsia have an increased risk of cardiovascular disease (CVD) later in life.However, current guidelines on cardiovascular risk assessment and prevention are unclear on how and when to screen these women postpartum, and about the role of a positive history of preeclampsia in later-life CVD risk management. The aim of this review is to discuss the present knowledge on commonly used cardiovascular screening modalities available to women with a history of preeclampsia, and to discuss recent developments in early detection of CVD using cardiovascular imaging.Furthermore, we explore how female-specific risk factors may have additional value in cardiovascular screening, in particular in relatively young women, although their implementation in clinical practice is challenged by inconsistent results and lack of long-term outcome data. Non-invasive imaging techniques, e.g. coronary artery intima-media thickness (CIMT), can be helpful to detect subclinical atherosclerotic disease, and coronary artery calcium scoring (CACS) has shown to be effective in early detection of cardiovascular damage. However, whilst more short-term and long-term follow-up studies are becoming available, few studies have investigated women with a history of preeclampsia in the fourth and fifth decade of life, when early signs of premature CVD are most likely to become apparent.Further studies are needed to inform new and improved clinical practice guidelines, and provide longterm strategies to effectively prevent CVD, specifically targeted at women with a history of preeclampsia. Additionally, evaluation of feasibility, cost-effectiveness ...

show abstract

Section: Cardiovascular Imagingmentioning

confidence: 99%

Section: Coronary Artery Calcium Scorementioning

confidence: 99%

Section: Coronary Artery Calcium Scorementioning

confidence: 99%

See 1 more Smart Citation

Determinants of future cardiovascular health in women with a history of preeclampsia

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Myocardial perfusion magnetic resonance imaging (MRI) is increasingly used as an accurate and reproducible technique for noninvasive diagnosis of coronary heart disease (CHD). Its potential advantages include a lack of ionizing radiation exposure, cost‐effectiveness, and additional information on cardiac anatomy, function, and tissue viability when performed as part of a multiparametric protocol 2, 3. Magnetic resonance (MR) perfusion imaging has high sensitivity and specificity as compared to x‐ray coronary angiography 4.…”

mentioning

confidence: 99%

Factors associated with false‐negative cardiovascular magnetic resonance perfusion studies: A Clinical evaluation of magnetic resonance imaging in coronary artery disease (CE‐MARC) substudy

Kidambi

Sourbron

Maredia

et al. 2015

Magnetic Resonance Imaging

View full text Add to dashboard Cite

PurposeTo examine factors associated with false‐negative cardiovascular magnetic resonance (MR) perfusion studies within the large prospective Clinical Evaluation of MR imaging in Coronary artery disease (CE‐MARC) study population. Myocardial perfusion MR has excellent diagnostic accuracy to detect coronary heart disease (CHD). However, causes of false‐negative MR perfusion studies are not well understood.Materials and MethodsCE‐MARC prospectively recruited patients with suspected CHD and mandated MR, myocardial perfusion scintigraphy, and invasive angiography. This subanalysis identified all patients with significant coronary stenosis by quantitative coronary angiography (QCA) and MR perfusion (1.5T, T 1‐weighted gradient echo), using the original blinded image read. We explored patient and imaging characteristics related to false‐negative or true‐positive MR perfusion results, with reference to QCA. Multivariate regression analysis assessed the likelihood of false‐negative MR perfusion according to four characteristics: poor image quality, triple‐vessel disease, inadequate hemodynamic response to adenosine, and Duke jeopardy score (angiographic myocardium‐at‐risk score).ResultsIn all, 265 (39%) patients had significant angiographic disease (mean age 62, 79% male). Thirty‐five (5%) had false‐negative and 230 (34%) true‐positive MR perfusion. Poor MR perfusion image quality, triple‐vessel disease, and inadequate hemodynamic response were similar between false‐negative and true‐positive groups (odds ratio, OR [95% confidence interval, CI]: 4.1 (0.82–21.0), P = 0.09; 1.2 (0.20–7.1), P = 0.85, and 1.6 (0.65–3.8), P = 0.31, respectively). Mean Duke jeopardy score was significantly lower in the false‐negative group (2.6 ± 1.7 vs. 5.4 ± 3.0, OR 0.34 (0.21–0.53), P < 0.0001).ConclusionFalse‐negative cardiovascular MR perfusion studies are uncommon, and more common in patients with lower angiographic myocardium‐at‐risk. In CE‐MARC, poor image quality, triple‐vessel disease, and inadequate hemodynamic response were not significantly associated with false‐negative MR perfusion. J. MAGN. RESON. IMAGING 2016;43:566–573.

show abstract

“…One of the important advantages of 3D echocardiographic volume measurements is that they do not rely on geometric assumptions. In patients with good image quality, 3D echocardiographic measurements are accurate and reproducible and should therefore be used when available and feasible LVEF [29]. Importantly, 2DE and CMR have been compared for the screening of CTRCD in adult survivors of childhood cancer exposed to anthracyclines or left chest radiation [18].…”

Section: Cardiac Magnetic Resonancementioning

confidence: 99%

Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity

2017

View full text Add to dashboard Cite

Contemporary cancer management has increased the overall number of cancer survivors, but cardiotoxicity remains a subject of concern, which is a major cause of noncancer mortality among survivors. Among the potential cardiovascular complications, left ventricular (LV) systolic dysfunction is a poor prognostic factor. The importance of its early detection is based on the principle that the likelihood of response to heart failure (HF) treatment is temporally related to the initiation of HF treatment. For these reasons, cardiac monitoring is commonly applied in general practice, based on serial measurements of LV ejection fraction (LVEF); transthoracic echocardiography (TTE) is generally used. However, the LVEF, as a diagnostic and predictive parameter, has significant limitations, which calls for more effective multimodality imaging strategies. This approach requires further study, but there is increasing available data in the literature, encouraging the combination of multimodality imaging parameters and techniques for early cancer therapeutic-related cardiac dysfunction (CTRCD) detection.

show abstract

ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance

Cited by 493 publications

References 439 publications

Determinants of future cardiovascular health in women with a history of preeclampsia

Determinants of future cardiovascular health in women with a history of preeclampsia

Factors associated with false‐negative cardiovascular magnetic resonance perfusion studies: A Clinical evaluation of magnetic resonance imaging in coronary artery disease (CE‐MARC) substudy

Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity

Contact Info

Product

Resources

About